Fulcrum Therapeutics, Slate Medicines announce merger agreement
Fulcrum Therapeutics and Slate Medicines announce a merger agreement to advance next-generation migraine therapies.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.